Incidence of neurosecretory dysfunction among children aged 6-14 years in Rehovot, Israel.

Z Zadik, A Kowarski
{"title":"Incidence of neurosecretory dysfunction among children aged 6-14 years in Rehovot, Israel.","authors":"Z Zadik,&nbsp;A Kowarski","doi":"10.1111/j.1651-2227.1989.tb17173.x","DOIUrl":null,"url":null,"abstract":"<p><p>Screening of 7500 children aged between 5.8 and 14.4 years, out of a total population of 39,690 in this age group in the Rehovot region, revealed 111 children with heights 2.5 SD below the mean for their age, according to the Tanner-Whitehouse standards. Included among these short children were eight with hypochondroplastic skeletal disease, two with Down's syndrome, four with thalassaemia, four with Turner's syndrome, three with coeliac disease, four with classical growth hormone (GH) deficiency, four with intrauterine growth retardation, four with systemic disease and 78 without obvious underlying causes. In 35 of the 78 children in the last group, the 24-hour integrated concentration of GH was in the hypopituitary range (less than 3.2 ng/ml), and GH neurosecretory dysfunction (NSD) was accordingly diagnosed. This represents an incidence of GH neurosecretory dysfunction of 45% among abnormally short children without underlying pathology, and is consistent with the authors' previous findings. The overall frequency of GH neurosecretory dysfunction in the screened population was 4/1000.</p>","PeriodicalId":75408,"journal":{"name":"Acta paediatrica Scandinavica. Supplement","volume":"349 ","pages":"77-80; discussion 81-3"},"PeriodicalIF":0.0000,"publicationDate":"1989-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1651-2227.1989.tb17173.x","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta paediatrica Scandinavica. Supplement","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/j.1651-2227.1989.tb17173.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16

Abstract

Screening of 7500 children aged between 5.8 and 14.4 years, out of a total population of 39,690 in this age group in the Rehovot region, revealed 111 children with heights 2.5 SD below the mean for their age, according to the Tanner-Whitehouse standards. Included among these short children were eight with hypochondroplastic skeletal disease, two with Down's syndrome, four with thalassaemia, four with Turner's syndrome, three with coeliac disease, four with classical growth hormone (GH) deficiency, four with intrauterine growth retardation, four with systemic disease and 78 without obvious underlying causes. In 35 of the 78 children in the last group, the 24-hour integrated concentration of GH was in the hypopituitary range (less than 3.2 ng/ml), and GH neurosecretory dysfunction (NSD) was accordingly diagnosed. This represents an incidence of GH neurosecretory dysfunction of 45% among abnormally short children without underlying pathology, and is consistent with the authors' previous findings. The overall frequency of GH neurosecretory dysfunction in the screened population was 4/1000.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
以色列Rehovot 6-14岁儿童神经分泌功能障碍发生率
在雷霍沃特地区这个年龄段的39,690名总人口中,对7500名年龄在5.8至14.4岁之间的儿童进行了筛查,根据Tanner-Whitehouse标准,发现111名儿童的身高比同龄儿童的平均身高低2.5个标准差。在这些矮小的儿童中,有8人患有骨质疏松症,2人患有唐氏综合症,4人患有地中海贫血,4人患有特纳氏综合症,3人患有乳糜泻,4人患有经典生长激素缺乏症,4人患有宫内生长迟缓,4人患有全身性疾病,78人没有明显的潜在原因。最后一组78例患儿中有35例24小时GH综合浓度在垂体功能低下范围内(小于3.2 ng/ml),诊断为GH神经分泌功能障碍(NSD)。这表明,在没有潜在病理的异常矮小儿童中,生长激素神经分泌功能障碍的发生率为45%,这与作者先前的研究结果一致。筛查人群中生长激素神经分泌功能障碍的总体频率为4/1000。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
11th International Symposium on Growth and Growth Disorders. Proceedings of a meeting, Stockholm, Sweden, 26-27 April 1991. 12th International Symposium on Growth and Growth Disorders. Geneva, 25-26 October 1991. The carbohydrate-deficient glycoprotein syndrome. A new inherited multisystemic disease with severe nervous system involvement. Growth hormone treatment in short children with chronic renal failure and after renal transplantation: combined data from European clinical trials. The European Study Group. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1